1. Rudolph AM, Heymann MA. The circulation of
the fetus in utero. Methods for studying distribution of blood flow,
cardiac output, and organ blood flow.
Circ Res. 1967;21:163-168.
[PubMed: 4952708]
2. Rudolph AM, Heymann MA. Circulatory changes during growth
in the fetal lamb.
Circ Res. 1970;26:289-299.
[PubMed: 5461210]
3. Rudolph AM, Heymann MA. Distribution and regulation of blood
flow in the fetal and neonatal lamb.
Circ Res. 1985;57:811-821.
[PubMed: 3905044]
4. Fishman NH, Hof RB, Rudolph AM, Heymann MA. Models of congenital
heart disease in fetal lambs.
Circulation. 1978;58:354-360.
[PubMed: 668085]
5. Winsberg F. Echocardiography of the fetal newborn heart.
Invest
Radiol. 1972;7:152-158.
[PubMed: 5064272]
6. Allan, LD, Tynan MJ, Campbell S, et al. Echocardiographic
and anatomical correlates in the fetus.
Br Heart J.
1980;44:444-447.
[PubMed: 7426207]
7. Lange LW, Sahn DJ, Allen HD, et al. Qualitative real-time
cross-sectional echocardiographic imaging of the human fetus during
the second half of pregnancy.
Circulation. 1980;62:799-805.
[PubMed: 7408152]
8. Sahn DJ, Lange LW, Allen HD, et al. Quantitative real-time
cross-sectional echocardiography in the developing normal human
fetus and newborn.
Circulation 1980;62:588-603.
[PubMed: 7398020]
9. Huhta JC, Hagler DJ, Hill LM. Two-dimensional echocardiographic
assessment of normal fetal cardic anatomy.
J Reprod Med. 1984;29:162-165.
[PubMed: 6726693]
10. Reed KL, Meijboom EJ, Sahn DJ, Scagneli SA, Valdes-Cruz LM,
Shenker L. Cardiac Doppler flow velocities in human fetuses.
Circulation 1986;73:41-46.
[PubMed: 3510089]
11. Kenny JF, Plappert T, Doubilet P, et al. Changes in intracardiac blood
flow velocities and right and left ventricular stroke volumes with
gestational age in the normal human fetus: a prospective Doppler
echocardiographic study.
Circulation. 1986;74:1208-1216.
[PubMed: 3779910]
12. Sutton MG, Plappert T, Doubilet P. Relationship between
placental blood flow and combined ventricular output with gestational age
in the normal fetus.
Cardiovasc Res. 1991;25:603-608.
[PubMed: 1913750]
13. Mielke G, Benda N. Cardiac output and central distribution
of blood flow in the human fetus.
Circulation. 2001;103:1662-1667.
[PubMed: 11273994]
14. Allan LD, Tynan MJ, Campbell S, Wilkinson JL, Anderson RH.
Identification of congenital cardiac malformations by echocardiography
in the midtrimester fetus.
Br Heart J. 1981;46:358-362.
[PubMed: 7295430]
15. Kleinman CS, Donnerstein RL, DeVore GR, et al. Fetal echocardiography
for the evaluation of in utero congestive heart failure.
N
Engl J Med. 1982;306:568-571.
[PubMed: 7035942]
16. Allan D, Crawford DC, Anderson RH, et al. Spectrum of congenital
heart disease detected echocardiographically in prenatal life.
Br
Heart J. 1985;54:523-526.
[PubMed: 4052293]
17. Sharland GK, Lockhart SM, Chita SK, Allan LD. Factors influencing
the outcome of congenital heart disease detected prenatally.
Arch
Dis Child. 1991;66:284-287.
[PubMed: 1827247]
18. Friedberg M, Silverman N. Changing indications for fetal echocardiography
in a university population. Prenat Diagn. 2004;24(10):781-786.
19. Bronshtein M, Zimmer EJ. The sonographic approach to the
detection of fetal cardiac anomalies in early pregnancy.
Ultrasound
Obstet Gynecol. 2002;19:360-365.
[PubMed: 11952965]
20. Achiron R, Rotstein Z, Lipitz S, Mashiach S, Hegesh J. First-trimester
diagnosis of fetal congenital heart disease by transvaginal ultrasonography.
Obstet
Gynecol. 1994;84:69-72.
[PubMed: 8008327]
21. Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH.
Fetal cardiac abnormalities identified prior to 14 weeks’ gestation. Ultrasound
Obstet Gynecol. 2002;20(1):22-29.
22. Carvalho JS, Moscoso G, Tekay A, Campbell S, Thilaganathan
B, Shinebourne EA. Clinical impact of first and early second trimester
fetal echocardiography on high risk pregnancies.
Heart.
2004;90:921-926.
[PubMed: 15253970]
23. Mcauliffe FM, Trines T, Nield LE, Chitayat D, Jaeggi E,
Hornberger LK. Early fetal echocardiography—a reliable
prenatal diagnosis tool.
Am J Obstet Gynecol. 2005;193:1253-1259.
[PubMed: 16157147]
24. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH.
Using fetal nuchal translucency to screen for major congenital cardiac
defects at 10-14 weeks of gestation: population based cohort study.
Br
Med J. 1999;318:81-85.
[PubMed: 9880278]
25. McAuliffe FM, Hornberger LK, Winsor S, Chitayat D, Chong
K, Johnson J. Fetal cardiac defects and increased nuchal translucency
thickness, a prospective study. Am J Obstet Gynecol.
2004;191 (4):1486-1490.
26. Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH.
Relation between increased fetal nuchal translucency thickness and
chromosomal defects.
Obstetr Gynecol 2006;107:6-10.
[PubMed: 16394033]
27. Simpson LL, Malone FD, Bianchi DW, et al. Nuchal translucency
and the risk of congenital heart disease.
Obstetr Gynecol. 2007;109:376-383.
[PubMed: 17267839]
28. Leiva MC, Tolosa JE, Binotto CN, Weiner S, Huppert L, Denis
AL, Huhta JC. Fetal cardiac development and hemodynamics in the
first trimester.
Ultrasound Obstetr Gynecol. 1999;14:169-174.
[PubMed: 10550875]
29. Wloch A, Rozmus-Warcholinska W, Czuba B, et al. Doppler study
of the embryonic heart in normal pregnant women. J Matern
Fetal Neonatal Med. 2007;20(7):533-539.
30. Rychik J, Ayres N, Cuneo B, et al. American Society of Echocardiography
guidelines and standards for performance of the fetal echocardiogram.
J
Am Soc Echo. 2004;17:803-810.
[PubMed: 15220910]
31. Allan LD, Sharland GK, Milburn A, et al. Prospective diagnosis
of 1,006 consecutive cases of CHD in the fetus.
J Am Coll
Cardiol. 1994;23:1452-1458.
[PubMed: 8176106]
32. Tometzki AJ, Suda K, Kohl T, Kovalchin JP, Silverman NH.
Accuracy of prenatal echocardiographic diagnosis and prognosis of
fetuses with conotruncal anomalies.
J Am Coll Cardiol. 1999;33:1696-1701.
[PubMed: 10334445]
33. Gottliebson WM, Border WL, Franklin CM, Meyer RA, Michelfelder
EC. Accuracy of fetal echocardiography: a cardiac segment specific analysis.
Ultrasound
I Obstetr Gynecol. 2006;28:15-21.
[PubMed: 16758441]
34. Taketazu M, Lougheed J, Yoo SJ, Hornberger LK. Fetal heterotaxy
syndrome: spectrum of heart disease, accuracy of diagnosis and clinical
outcome. Am J Cardiol. 2006:97(5):720-724.
35. Berning RA, Silverman NH, Villegas M, Sahn DJ, Martin GR, Rice
MJ. Reversed shunting across the ductus arteriosus or atrial septum
in utero heralds severe congenital heart disease. J Am Coll
Cardiol. 1996;27(2):481-486.
36. Friedberg MK, Silverman, NH, Anita Moon-Grady
A, et al. Prenatal detection of congenital heart disease. J
Pediatr 2009;15:26-31.
37. Song S-S, Hu A, Dyhamenahali U, et al. Extracardiac lesions
and chromosomal abnormalities associated with major fetal heart
defects: a comparison of intrauterine, postnatal and postmortem
diagnoses. J Ultrasound Obstetr Gynecol. 2009;33(5):552-559.
38. Paladini D, Calabro R, Palmieri S, D’Andrea T. Prenatal
diagnosis of congenital heart disease and fetal karyotyping. Obstet
Gynecol. 1993;181:679-682.
39. Rustico MA, Benettoni A, D’Ottavio G, et al. Fetal
heart screening in low-risk pregnancies. Ultrasound Obstet
Gynecol 1995;50:331-339.
40. Hafner E, Scholler J, Schuchter K, Sterniste W, Philipp K.
Detection of fetal congenital heart disease in a low-risk population.
Prenat
Diagn. 1998;18:808-815.
[PubMed: 9742568]
41. Jaeggi ET, Sholler GF, Jones OD, Cooper SG. Comparative analysis
of pattern, management and outcome of pre- versus postnatally diagnosed
major congenital heart disease: a population-based study.
Ultrasound
Obstet Gynecol. 2001;17:380-385.
[PubMed: 11380960]
42. Shipp TD, Bromley B, Hornberger LK, Nadel A, Benacerraf BR.
Levorotation of the fetal cardiac axis: a clue for the presence
of congenital heart disease.
Obstet Gynecol. 1995;85:97-102.
[PubMed: 7800334]
43. Hornberger LK, Trines J. Evolution of congenital heart disease in
utero. Pediatric Cardiology. PA Pediatr Cardiol.
2004;25(3):287-298.
44. Hornberger L, Sanders SP, Rein AJJT, et al. Left heart obstructive
lesions and left ventricular growth in the midtrimester fetus. A
longitudinal study.
Circulation. 1995;92:1531-1538.
[PubMed: 7664437]
45. Simpson JM, Sharland GK. Natural history and outcome of aortic
stenosis diagnosed prenatally.
Heart. 1997;77:205-210.
[PubMed: 9093035]
46. Hornberger LK, Need L, Benacerraf BR. Development of significant
left and right ventricular hypoplasia in the second and third trimester
fetus. J Ultrasound Med. 1996;15:60-65.
47. Mäkikallio K, McElhinney DB, Levine JC, et al. Fetal
aortic valve stenosis and the evolution of hypoplastic left heart
syndrome: patient selection for fetal intervention. Circulation.
2006;113(11): 1401-1405.
48. Kohl T, Sharland G, Allan LD, et al. World experience of
percutaneous ultrasound-guided balloon valvuloplasty in human fetuses
with severe aortic valve obstruction. Am J Cardiol.
2000;15;85 (10):1230-1233.
49. Arzt W, Tulzer G, Aigner M, Mair R, Hafner E. Invasive intrauterine
treatment of pulmonary atresia/intact ventricular septum with
heart failure. Ultrasound Obstet Gynecol. 2003;21(2):186-188.
50. Tworetzky W, Wilkins-Haug L, Jennings RW, et al. Balloon
dilation of severe aortic stenosis in the fetus: potential for prevention of
hypoplastic left heart syndrome: candidate selection, technique, and
results of successful intervention. Circulation. 2004;110(15):2125-2131.
51. Marshall AC, van der Velde ME, Tworetzky W, et al. Creation of
an atrial septal defect in utero for fetuses with hypoplastic left heart
syndrome and intact or highly restrictive atrial septum. Circulation.
2004;110(3):253-258.
52. Tulzer G, Gudmundsson S, Sharkey AM, Wood DC, Cohen AW,
Huhta JC. Doppler echocardiography of fetal ductus arteriosus constriction
versus increased right ventricular output.
J Am Coll Cardiol.
1991;18:532-536.
[PubMed: 1856423]
53. Leal SD, Cavalle-Garrido T, Ryan G, Farine D, Heilbut M, Smallhorn
JF. Isolated ductal closure in utero diagnosed by fetal echocardiography. Am
J Perinatol. 1997;14(4):205-210.
54. Chobot V, Hornberger LK, Hagen-Ansert S, Sahn DJ. Prenatal
detection of restrictive foramen ovale. J Am Soc Echocardiogr.
1990:3(1):15-19.
55. Jaeggi ET, Fouron J-C, Hornberger LK, Proulx F, Iberhaensli-Weiss
I, Fermont L. Agenesis of the ductus venosus associated with extrahepatic
umbilical vein drainage: clinical presentation, echocardiographic
features and fetal outcome. Am J Obstet Gynecol.
2002:187(4):1031-1037.
56. Korner H, Bommer CH, Chaoui R, Tennstedt C, Bollmann R, Lehmann
K. Karyotype findings in fetuses with cardiac abnormalities detected
prenatally. Med Genet. 1997;9:65.
57. Allan LD, Sharland GK, Chita SC, Lockhart S, Maxwell DJ. Chromosomal
anomalies in fetal congenital heart disease.
Ultrasound
Obstet Gynecol. 1991;1:8-11.
[PubMed: 12797095]
58. Williams C, Munson D, Zupancic J, Kirpalani H. Supporting
bereaved parents: practical steps in providing compassionate perinatal
and neonatal end-of-life care. A North American perspective.
Semin
Fetal Neonatal Med. 2008;13:335-340.
[PubMed: 18472317]
59. Kleinman CS, Nehgme RA. Cardiac arrhythmias in the fetus.
Pediatr
Cardiol. 2004;25:234-251.
[PubMed: 15360116]
60. Gardiner HM, Belmar C, Pasquini L, et al. Fetal ECG: a novel
predictor of atrioventricular block in anti-Ro positive pregnancies.
Heart.
2007;93: 1454-1460.
[PubMed: 17085531]
61. Quartero HWP, Stinstra JG, Golbach EGM, Meijboom EJ, Peters
MJ. Clinical implications of fetal magnetocardiography.
Ultrasound
Obstetr Gynecol. 2002;20:142-153.
[PubMed: 12153665]
62. Wakai RT, Strasburger JF, Li Z, et al. Magnetocardiographic rhythm
patterns at initiation and termination of fetal supraventricular
tachycardia.
Circulation. 2003;107:307-312.
[PubMed: 12538433]
63. Fouron JC, Proulx F, Miro J, Gosselin J. Doppler and M-mode ultrasonography
to time fetal atrial and ventricular contractions.
Obstet
Gynecol. 2000;96:732-736.
[PubMed: 11042309]
64. Fouron JC. Fetal arrhythmias: the Sainte-Justine hospital
experience.
Prenat Diagn. 2004;24:1068-1080.
[PubMed: 15612055]
65. Rein AJJT, O’Donnell CO, Geva T, et al. Use of tissue
velocity imaging in the diagnosis of fetal cardiac arrhythmias.
Circulation.
2002;106:1827-1833.
[PubMed: 12356637]
66. Schmidt MR, Kristiansen SB, White P, et al. Glucose insulin
infusion improves cardiac function in fetal tachycardia.
JACC.
2004;43:445-452.
[PubMed: 15013129]
67. Schmidt MR, Smerup M, Kristiansen SB, et al. Maternal hyperglycemia
improves fetal cardiac function during tachycardia induced heart
failure in pigs.
Circulation. 2004;110:2627-2630.
[PubMed: 15313957]
68. Simpson JM, Sharland G. Fetal tachycardias: management and outcome
of 127 cases.
Heart. 1998;79:576-581.
[PubMed: 10078084]
69. Oudijk MA, Gooskens RH, Stoutenbeek P, De Vries LS, Visser
GH, Meijboom EJ. Neurological outcome of children who were treated
for fetal tachycardia complicated by hydrops.
Ultrasound
Obstet Gynecol. 2004;24:154-158.
[PubMed: 15287052]
70. Naheed ZJ, Strasburger JF, Deal BJ, Benson DW Jr, Gidding SS.
Fetal tachycardia: mechanisms and predictors of hydrops fetalis.
J
Am Coll Cardiol. 1996;27:1736-1740.
[PubMed: 8636562]
71. Van Engelen AD, Weijtens O, Brenner JI, et al. Management, outcome
and follow-up of fetal tachycardia. J Am Coll Cardiol. 1994;24:1371-1375.
72. Hansmann M, Gembruch U, bald R, Manz M, Redel DA. Fetal tachycardias:
transplacental and direct treatment of the fetus-A report of 60
cases.
Ultrasound Obstetr Gynecol. 1991;1:162-170.
[PubMed: 12797066]
73. Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander
NS, Wladimiroff JW, Hess J. The efficacy of flecainide versus digoxin in
the management of fetal supraventricular tachycardia.
Prenat
Diagn. 1995;15:1297-1302.
[PubMed: 8710768]
74. Schmolling J, Renke K, Richter O, Pfeiffer K, Schlebusch
H, Holler T. Digoxin, flecainide and amiodarone transfer across
the placenta and the effects of an elevated umbilical venous pressure on
transfer rate.
Ther Drug Monit. 2000;22:582-588.
[PubMed: 11034264]
75. Jaeggi E, Fouron JC, Drblik SP. Fetal atrial flutter: diagnosis, clinical
features, treatment, and outcome.
J Pediatr. 1998;132:335-339.
[PubMed: 9506651]
76. Jaeggi E, Fouron JC, Fournier A, van Doesburg NH, Drblik
SP, Proulx F. Ventriculo-atrial time interval measured on M-mode echocardiography:
a determining element in the diagnosis, treatment and prognosis
of fetal supraventricular tachycardia.
Heart. 1998;79:582-587.
[PubMed: 10078085]
77. Azancot-Benisty A, Jacqz-Aigrain E, Guirguis NM, Decrepy A,
Oury JF, Blot P. Clinical and pharmacological study of fetal supraventricular
tachyarrhythmias.
J Pediatr. 1992;121:608-613.
[PubMed: 1403399]
78. Allan LD, Chita SK, Sharland GK, Maxwell D, Priestley K. Flecainide
in the treatment of fetal tachycardias.
Br Heart J.
1991;65:46-48.
[PubMed: 1899583]
79. Sonesson SE, Fouron JC, Wesslen-Eriksson E, Jaeggi E, Winberg
P. Foetal supraventricular tachycardia treated with sotalol.
Acta
Paediatr. 1998;87:584-587.
[PubMed: 9641744]
80. Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment
of fetal dysrhythmias.
Circulation. 2000;101:2721-2726.
[PubMed: 10851210]
81. Jouannic JM, Delahaye S, Fermont L, et al. Fetal supraventricular
tachycardia: a role for amiodarone as second-line therapy?
Prenat
Diagn. 2003;23:152-156.
[PubMed: 12575024]
82. Triedman JK, Walsh EP, Saul JP. Response of fetal tachycardia to
transplacental procainamide. Cardiol Young. 1996;6:235-238.
83. Oudjik MA, Ruskamp JM, Ververs FFT, et al. Treatment of
fetal tachycardia with sotalol: transplacental pharmacokinetics
and pharmacodynamics. J Am Coll Cardiol. 2003;42:765-770.
84. Jouannic JM, Delahaye S, Fermont L, et al. Fetal supraventricular
tachycardia: a role for amiodarone as second-line therapy?
Prenat
Diagn. 2003;23:152-156.
[PubMed: 12575024]
85. Strasburger JF, Cuneo BF, Michon MM, et al. Amiodarone therapy
for drug-refractory fetal tachycardia.
Circulation.
2004;109:375-379.
[PubMed: 14732753]
86. Kohl T, Tercanli S, Kececioglu D, Holzgreve W. Direct fetal
administration of adenosine for the termination of incessant supraventricular
tachycardia.
Obstet Gynecol. 1995;85:873-874.
[PubMed: 7724143]
87. Flack NJ, Zosmer N, Bennett PR, Vaughan J, Fisk NM. Amiodarone
given by three routes to terminate fetal atrial flutter associated
with severe hydrops. Obstet Gynecol. 1993;82:483-486.
88. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA.
Perinatal outcome of fetal complete atrioventricular block: a multicenter
experience.
J Am Coll Cardiol. 1991;17:1360-1366.
[PubMed: 2016455]
89. Jaeggi ET, Hornberger LK, Smallhorn JF, Fouron J-C. Prenatal
diagnosis of complete atrio-ventricular block associated with structural
heart disease since 1990: combined experience of 2 tertiary care centers
and review of the literature.
Ultrasound Obstetr Gynecol. 2005;26:16-21.
[PubMed: 15937969]
90. Zhao H, Cuneo BF, Strasburger JF, Huhta JC, Gotteiner NL, Wakai
RT. Electrophysiologic characteristics of fetal AV block.
J
Am Coll Cardiol. 2008;51:77-84.
[PubMed: 18174041]
91. Buyon JP, Heibert R, Copel J, et al. Autoimmune-associated
congenital heart block: demographics, mortality, morbidity and recurrence
rates obtained from a national lupus registry.
J Am Coll
Cardiol. 1998;31:1658-1666.
[PubMed: 9626848]
92. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger
LK. Outcome of children with fetal, neonatal or childhood diagnosis
of isolated congenital atrioventricular block. A single institution’s
experience of 30 year experience.
J Am Coll Cardiol. 2002;39:130-137.
[PubMed: 11755298]
93. Cimaz RG, Spence D, Hornberger LK, Silverman ED. Defining
the incidence and spectrum of neonatal lupus erythematosus: a prospective
study of infants born to mothers with anti-Ro autoantibodies. J
Pediatr. 2003;142(6):678-683.
94. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger
LK. Transplacental treatment improves the outcome of prenatally
diagnosed complete atrioventricular block without structural heart
disease.
Circulation. 2004;110:1542-1548.
[PubMed: 15353508]
95. Nield LE, Silverman ED, Taylor GP, et al. Maternal anti-Ro
and anti-La antibody associated endocardial fibroelastosis.
Circulation.
2002;105:843-848.
[PubMed: 11854125]
96. Moak JP, Barron KS, Hougen TJ, et al. Congenital heart block: development
of late-onset cardiomyopathy, a previously underappreciated sequela.
J
Am Coll Cardiol. 2001;37:238-242.
[PubMed: 11153745]
97. Nield LE, Silverman ED, Smallhorn JF, et al. Endocardial
fibroelastosis associated with maternal anti-Ro and anti-La antibodies
in the absence of atrioventricular block. J Am Coll Cardiol. 2002:40:796-802.
98. Lopes LM, Tavares GM, Damiano AP, et al. Perinatal outcome
of fetal atrioventricular block: one-hundred-sixteen cases from
a single institution. Circulation. 2008;118(12):1268-1275.
99. Gudmundsson S, Huhta JC, Wood DC, et al. Venous Doppler
ultrasonography in the fetus with nonimmune hydrops.
Am
J Obstet Gynecol. 1991;164:33-37.
[PubMed: 1986621]
100. Brace RA. Effects of outflow pressure on fetal lymph flow.
Am
J Obstet Gynecol. 1989;160:494-497.
[PubMed: 2916638]
101. Brace RA, Valenzuela GJ. Effects of outflow pressure and
vascular volume loading on thoracic duct lymph flow in adult sheep. Am
J Physiol. 1990;258:R240-244.
102. Rudolph AM. The Fetal Circulation and Postnatal
Adaptation. Congenital Diseases of the Heart: Clinical-Physiological
Considerations. Armonk, NY: Futura; 2001:38-43.
103. Hornberger LK, Nii M. Heart failure in the fetus. In: Shaddy
RE, Wernovsky G, eds. Pediatric Heart Failure.
Boca Raton, FL: Taylor & Francis; 2005:171-207.
104. Inamura N, Taketasu M, Smallhorn JF, Hornberger LK. Left
ventricular myocardial performance in the fetus with severe tricuspid
valve disease and tricuspid insufficiency Am J Perinatol.
2005;22(2):91-97.
105. Inamura N, Kado Y, Nakajima T, Kayatani F. Left and right
ventricular function in fetal tetralogy of Fallot with absent pulmonary
valve. Am J Perinatol. 2005;22(4):199-204.
106. Fontes-Pedra SRF, Smallhorn J, Ryan G, et al. Fetal cardiomyopathies:
etiologies, hemodynamic findings and clinical outcome. Circulation. 2002;106:585-591.
107. Barrea C, Alkazaleh F, Ryan G, et al. Prenatal cardiovascular
manifestations in twin-to-twin transfusion syndrome (TTTS) and the
impact of therapeutic amnioreduction. Am J Obstet Gynecol.
2005;192(3):892-902.
108. Barrea C, Hornberger LK, Alkazaleh F, et al. Impact of
selective laser ablation of placental anastomoses in twin-to-twin
transfusion syndrome on the cardiovascular pathology of the recipient
twin.
Am J Obstet Gynecol. 2006;195: 1388-1395.
[PubMed: 16777050]
109. Wald R, Adatia I, Van Arsdell G, Hornberger LK. Improving
survival in neonatal Ebstein’s anomaly: the importance
of limiting ductal patency. Am J Cardiol. 2005;96(6):851-856.
110. Glatz AC, Gaynor JW, Rhodes LA, et al. Outcome of high-risk
neonates with congenital complete heart block paced in the first
24 hours after birth. J Thorac Cardiovasc Surg.
2008;136(3):767-773.
111. Bader R, Huhta J. Section III. Left heart abnormalities:
coarctation of the aorta. In: Bader RS, Hornberger LK, Huhta JC,
eds. The Perinatal Cardiology Handbook. New York:
Mosby Elsevier; 2008:187.
112. Maeno Y, Kamenir SA, Sinclair B, Smallhorn JF, Vandervelde
M, Hornberger LK. Prenatal features of ductus arteriosus constriction
and foramen ovale restriction in d-transposition of the great arteries. Circulation. 1999:99:1209-1214.
113. Jouannic JM, Gavard L, Fermont L, et al. Sensitivity and
specificity of prenatal features of physiological shunts to predict
neonatal clinical status in transposition of the great arteries. Circulation.
2004;110(13):1743-1746.
114. Franklin O, Burch M, Manning N, et al. Prenatal diagnosis
of coarctation of the aorta improves survival and reduces morbidity.
Heart. 2002;
87:67-69.
[PubMed: 11751670]
115. Satomi G, Yasukochi S, Shimizu T, et al. Has fetal echocardiography
improved the prognosis of congenital heart disease? Comparison of patients
with hypoplastic left heart syndrome with and without a prenatal
diagnosis.
Pediatr Int. 1999;41:728-732.
[PubMed: 10618902]
116. Mahle WT, Clancy RR, McGaurn SP, et al. Impact of prenatal
diagnosis on survival and early neurologic morbidity in neonates
with the hypoplastic left heart syndrome.
Pediatrics. 2001;107:1277-1282.
[PubMed: 11389243]
117. Verheijen PM, Lisowski LA, Stoutenbeek P, et al. Prenatal
diagnosis of congenital heart disease affects preoperative acidosis
in the newborn patient.
J Thorac Cardiovasc Surg. 2001;121:798-803.
[PubMed: 11279423]
118. Copel JA, Tan AS, Kleinman CS. Does a prenatal diagnosis
of congenital heart disease alter short-term outcome?
Ultrasound
Obstet Gynecol. 1997; 10(4):237-241.
[PubMed: 9383873]
119. Allan LD, Cook A, Sullivan I, Sharland GK. Hypoplastic
left heart syndrome: effects of fetal echocardiography on birth
prevalence.
Lancet. 1991;337:959-961.
[PubMed: 1678041]
120. Daubeney PE, Sharland GK, Cook AC, Keeton BR, Anderson
RH, Webber SA. Pulmonary atresia with intact ventricular septum:
impact of fetal echocardiography on incidence at birth and postnatal
outcome. UK and Eire Collaborative Study of Pulmonary Atresia with
Intact Ventricular Septum.
Circulation. 1998;98:562-565.
[PubMed: 9714114]
121. Leuthner S, Bolger M, Frommelt M, Nelson R. The impact
of abnormal fetal echocardiography on expectant parents’ experience
of pregnancy: a pilot study.
J Psychosom Obstetr Gynecol. 2003;
24:121-129.
[PubMed: 12854396]
122. Rustico MA, Benettoni A, D’Ottavio G, et al. Fetal
heart screening in low-risk pregnancies. Ultrasound Obstet
Gynecol. 1995;50:331-339.
123. Hafner E, Scholler J, Schuchter K, Sterniste W, Philipp
K. Detection of fetal congenital heart disease in a low-risk population.
Prenat
Diagn. 1998;18:808-815.
[PubMed: 9742568]
124. Grembruch U. Prenatal diagnosis of congenital heart disease. Prenat
Diagn. 1997;17:1283-1298.
125. Hofbeck M, Rauch R, Beinder E, Buheitel G, Leipold G, Rauch
A, Singer H. Rate of prenatal detection of congenital heart defects. Z
geburtshilfe Neonatol. 1999;203(5):207-212.
126. Jaeggi ET, Sholler GF, Jones OD, Cooper SG. Comparative
analysis of pattern, management and outcome of pre- versus postnatally
diagnosed major congenital heart disease: a population-based study.
Ultrasound
Obstet Gynecol. 2001;17:380.
[PubMed: 11380960]